AMSBIO announce the availability of recombinant proteins and antibodies for detection of Coronavirus (COVID-19) and related RNA viruses. Historically strains of Coronavirus able to infect humans (HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoVHKU1) were not highly pathogenic and only caused mild respiratory illness. By comparison more recent strains - SARS-CoV, MERS-CoV and COVID-19 that emerged in Wuhan, China at the end of [...]

Speed and scale of Fluidigm microfluidics technology to facilitate early-stage host monitoring for COVID-19 SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that a consortium of medical schools led by the Icahn School of Medicine at Mount Sinai [...]

SOUTH SAN FRANCISCO, Calif.-- Twist Bioscience Corporation (Nasdaq: TWST) today announced the availability of Research-Use Only (RUO) target enrichment next-generation sequencing (NGS) panels for viral detection and characterization of samples from patients testing positive for SARS-CoV-2, the virus which causes COVID-19. These panels can be used for environmental monitoring and surveillance testing, while also providing [...]

Uppsala, Sweden: Gyros Protein Technologies AB, a Mesa Laboratories, Inc. (NASDAQ:MLAB) company, and pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and the Jefferson Institute for Bioprocessing (JIB) at Thomas Jefferson University, a leading center of excellence providing advanced training to the bioprocessing industry, today announced that Gyrolab xPlore™ immunoassay system from Gyros Protein Technologies will [...]

Mitsubishi Chemical Corporation (MCC; Head office: Chiyoda-ku, Tokyo Japan), a parent company of Mitsubishi Chemical Analytech Co., Ltd. (MCAT; Head office: Yamato, Kanagawa Japan), announced on 28th February 2020 an agreement to transfer MCAT’s entire business and assets to Nittoseiko Co., Ltd. (NSC: Head office; Ayabe, Kyoto, Japan) effective on 1st April 2020. The new [...]

Aiming for new growth stage incorporating the changing business environment and technological innovation Azbil Corporation has announced the appointment of Kiyohiro Yamamoto, currently managing executive officer, as executive vice president effective as of April 1, 2020. At the same time, current President and Chief Executive Officer of the azbil Group Hirozumi Sone will assume the [...]

(UPM, Helsinki) – UPM Biomedicals and Nichirei Biosciences Inc. signed an agreement on 1 March 2020 to offer the full range of UPM cell culture products to life sciences researchers in Japan. This agreement will provide the country’s cell biology community with direct access to UPM’s GrowDex® hydrogels for the first time, supporting advanced cell [...]

Sengenics, a leading precision medicine company, today announced that the company has made full-length, correctly folded and functional COVID-19 antigens available for purchase for both research and vaccine development purposes. Sengenics has successfully expressed these antigens using the company’s patented and validated KREX™ technology. ”The surge of COVID-19 infections has pushed us to accelerate the production [...]

With the beginning of 2020, Park Systems, a leading innovator of atomic force microscopy (AFM) technology, increases the business investment in Europe by inaugurating a new scientific facility for academic and industrial research in Mannheim, Germany. The Grand Opening Ceremony of the new Nanoscience Center Europe took place Tuesday, February 18, 2020, gathering customers, collaborators [...]

LEIDEN, The Netherlands -- Toxys is an innovative Dutch biotech company that develops unique animal-free laboratory tests for the safety assessment of novel medicines, chemicals, cosmetics and food. Today, Toxys announces a €2 million funding round from KIKK Capital, InnovationQuarter, Zeeland Investment fund, Toxys management and Rabobank. This investment is being made to advance Toxys’ ambition to become the global [...]